ArticleNPJ precision oncology2022

SRC-RAC1 signaling drives drug resistance to BRAF inhibition in de-differentiated cutaneous melanomas.

Eliot Y Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.